Chasing Hippos: Implications of YAP1 and TAZ Expression in Pregnancy-associated Breast Cancer Tumorigenesis

Anastasios Kyriazoglou(Alexandra Hospital), Flora Zagouri(National and Kapodistrian University of Athens)

In Vivo

January 1, 2022

10.21873/invivo.13027

Cited by 1

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

|New England Journal of Medicine|2022|2.5k

Protein expression patterns of cell cycle regulators in operable breast cancer

|PLoS ONE|2017|43

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

|ESMO Open|2020|38